Search Login Register
Congenital Ichthyosiform Erythroderma
Summary
Description:
Designation for several severe forms of ichthyosis, present at birth, that are characterized by hyperkeratotic scaling. Infants may be born encased in a collodion membrane which begins shedding within 24 hours. This is followed in about two weeks by persistent generalized scaling. The forms include bullous (HYPERKERATOSIS, EPIDERMOLYTIC), non-bullous (ICHTHYOSIS, LAMELLAR), wet type, and dry type.
Also Known As:
Ichthyosiform Erythroderma, Congenital; Congenital Ichthyosiform Erythroderma, Dry Type; Congenital Ichthyosiform Erythroderma, Wet Type; Erythroderma, Congenital Ichthyosiform; Congenital Ichthyosiform Erythrodermas Show All >>
Networked: 26
relevant articles (2 outcomes,
2 trials/studies)
for this Disease
Key Drugs and Agents for Congenital Ichthyosiform Erythroderma
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Tretinoin (Retinoic Acid)
:
1 outcome in 2 results
:
FDA 27
Generic
-
Alkanes
:
1 study in 2 results
: IBA
-
RNA Splice Sites
:
1 study in 1 result
: IBA
-
Carbon
:
1 study in 1 result
: IBA
-
Collodion (Nitrocellulose)
:
5 results
: IBA
-
transglutaminase 1
:
5 results
: IBA
-
Diffuse alopecia
:
2 results
: IBA
-
Nonsense Codon (Nonsense Mutation)
:
1 result
: IBA
-
Vitamin B 12 (Cyanocobalamin)
:
1 result
:
FDA 47
Generic
-
Lipid A
:
1 result
: IBA
Show All >>
Diseases Related to Congenital Ichthyosiform Erythroderma
-
Exfoliative Dermatitis (Erythroderma)
-
Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris)
-
Postherpetic Neuralgia
-
Warts (Wart)
-
Vitiligo
Show All >>
Key Therapies for Congenital Ichthyosiform Erythroderma
Efficacy Chart >>
-
Hypnosis (Mesmerism)
:
1 outcome in 2 results
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.